The Diltiazem Extended-Release Capsu, cataloged under National Stock Number 6505-01-505-4619, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sun Pharmaceutical Industries, Inc.. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-505-4619 |
| Primary Part Number | NDC47335-0669-81 |
| Item Name | Diltiazem Extended-Release Capsu |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sun Pharmaceutical Industries, Inc. |
| Status | ACTIVE |
| Administration | ORAL |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 90.000 |
| American Hospital Formulary Service Classification Number | 240400 |
| Active Medicament Medicinal Strength | 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC47335-0669-81 PRIMARY | Sun Pharmaceutical Industries, Inc. (USA) |
| NDC68682-0367-90 PRIMARY | Bausch Health Us Llc (USA) |
| Reference | Meaning |
|---|---|
| 03-0044 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-505-4619 is a Diltiazem Extended-Release Capsu, manufactured by Sun Pharmaceutical Industries, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-505-4619 has 2 manufacturer part numbers on file: NDC47335-0669-81 (Sun Pharmaceutical Industries, Inc.), NDC68682-0367-90 (Bausch Health Us Llc).
Key specifications for NDC47335-0669-81: Administration: ORAL; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 90.000. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.